참고문헌 (35)

1. Semin Liver Dis Margolis 11 84 1991 10.1055/s-2008-1040427 Hepatitis B: evolving epidemiology and implications for control 

   상세보기

2. Clin Microbiol Rev Mahoney 12 351 1999 10.1128/CMR.12.2.351 Update on diagnosis, management, and prevention of hepatitis B virus infection 

   상세보기

3. Br J Surg Pugh 60 646 1973 10.1002/bjs.1800600817 Transection of the esophagus for bleeding esophageal varices 

   상세보기

4. Hepatology Christensen 4 430 1984 10.1002/hep.1840040313 Prognostic value of Child-Turcotte cirteria in medically treated cirrhosis 

   상세보기

5. Ann Intern Med Weissberg 101 613 1984 10.7326/0003-4819-101-5-613 Survival in chronic hepatitis B. An analysis of 379 patients 

   상세보기

6. Gastroenterology de Jongh 103 1630 1992 10.1016/0016-5085(92)91188-A Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver 

   상세보기

7. Hepatology Donato 26 579 1997 10.1002/hep.510260308 Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case-control study in Italy 

   상세보기

8. J Infect Dis Fattovich 155 931 1987 10.1093/infdis/155.5.931 Influence of hepatitis Delta virus infection on progression to cirrhosis in chronic hepatitis B 

   상세보기

9. J Hepatol Realdi 21 656 1994 10.1016/S0168-8278(94)80115-0 Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. The Investigators of the European Concerted Action on Viral Hepatitis 

   상세보기

10. Hepatology Liaw 13 627 1991 10.1002/hep.1840130403 Incidence, determinants, and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: a prospective study 

    상세보기

11. N Engl J Med Lee 337 1733 1997 10.1056/NEJM199712113372406 Hepatitis B virus infection 

    상세보기

12. N Engl J Med Dienstag 341 1256 1999 10.1056/NEJM199910213411702 Lamivudine as initial treatment for chronic hepatitis B in the United States 

    상세보기

13. N Engl J Med Lai 339 61 1998 10.1056/NEJM199807093390201 A one year trial of lamivudine for chronic hepatitis B 

    상세보기

14. Gastroenterolgy Perrillo 109 908 1995 10.1016/0016-5085(95)90401-8 Low dose, titratable interferon alfa in decompensated liver disease caused by chronic infection with hepatitis B virus 

    상세보기

15. Gastroenterology Hoofnagle 104 1116 1993 10.1016/0016-5085(93)90281-G Interferon alfa for patients with clinically apparent cirrhosis due to chronic hepatitis B 

    상세보기

16. Hepatology Tassopoulos 29 889 1999 10.1002/hep.510290321 Efficacy of lamivudine in patients with hepatitis B e antigen-negative/ hepatitis B virus DNA positive (Precore mutant) chronic hepatitis B 

    상세보기

17. Hepatology Schiff 28 388A 1998 A placebo controlled study of lamivudine and interferon alpha-2b in patients with chronic hepatitis B who previously failed interferon therapy 

18. Hepatology Villeneuve 31 207 2000 10.1002/hep.510310130 Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B 

    상세보기

19. Hepatology Perrillo 30 301A 1999 Lamivudine for suppression of viral replication in patients with decompensated chronic hepatitis B 

20. J Hepatol Yao 33 301 2000 10.1016/S0168-8278(00)80371-2 Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection 

    상세보기

21. J Hepatol Kapoor 33 308 2000 10.1016/S0168-8278(00)80372-4 Beneficial effects of lamivudine in hepatitis B virus related decompensated cirrhosis 

    상세보기

22. Transplantation Fontana 67 S16 1999 10.1097/00007890-199904150-00068 Is lamivudine beneficial in HBsAg+ patients awaiting liver transplantation? Experience in 182 North American patients 

    상세보기

23. J Hepatol Leung 30 Suppl 1 59 1999 Three year lamivudine therapy in chronic HBV 

24. Antiviral Therapy Chang 5 Suppl. 1 44 2000 Incremental increases in HBeAg seroconversion and continued ALT normalization in Asian chronic HBV patients treated with lamivudine for four years 

25. Hepatology Melegari 27 628 1998 10.1002/hep.510270243 Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective 

    상세보기

26. J Hepatol Honkoop 26 1393 1997 10.1016/S0168-8278(97)80476-X Lamivudine resistance in immunocompetent chronic hepatitis B 

    상세보기

27. Lancet Bartholomew 349 20 1998 10.1016/S0140-6736(96)02266-0 Hepatitis-B-virus resistance to lamvudine given for recurrent infection after orthotopic liver transplantation 

    상세보기

28. Hepatology Liaw 30 567 1999 10.1002/hep.510300221 Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamvudine therapy 

    상세보기

29. J Hepatol Mutimer 30 715 1999 10.1016/S0168-8278(99)80204-9 High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation 

    상세보기

30. J Infect Dis Mutimer 181 713 2000 10.1086/315238 Selection of multiresistant hepatitis B virus during sequential nucleoside-analogue therapy 

    상세보기

31. J Hepatol de Man 29 669 1998 10.1016/S0168-8278(98)80164-5 The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B: hepatitis B immune globulin escape, famiciclovir non-response, followed by lamivudine resistance resulting in graft loss 

    상세보기

32. Hepatology Xiong 28 1669 1998 10.1002/hep.510280629 Mutations in hepatitis B DNA polymerase with resistance to lamvudine do not confer resistance to adefovir in vitro 

    상세보기

33. Gastroenterology Perrillo 116 L0356 1999 In vivo demonstration of sensitivity of YMDD mutants to adefovir 

34. J Infect Dis Gauthier 180 1757 1999 10.1086/315147 Quantitation of hepatitis B viremia and emergence of YMDD variants in patients with chronic hepatitis B treated with lamivudine 

    상세보기

35. Hepatology Perrillo 29 1581 1999 10.1002/hep.510290507 Multicenter study of lamivudine therapy for hepatitis B after liver transplantation 

    상세보기

활용도 Top5 논문

더보기

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.